|
|
|
|
LEADER |
02579 am a22002293u 4500 |
001 |
97501 |
042 |
|
|
|a dc
|
100 |
1 |
0 |
|a Zheng, Tengfei
|e author
|
100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Chemistry
|e contributor
|
100 |
1 |
0 |
|a Zheng, Tengfei
|e contributor
|
100 |
1 |
0 |
|a Nolan, Elizabeth M.
|e contributor
|
700 |
1 |
0 |
|a Nolan, Elizabeth M.
|e author
|
245 |
0 |
0 |
|a Enterobactin-Mediated Delivery of β-Lactam Antibiotics Enhances Antibacterial Activity against Pathogenic Escherichia coli
|
260 |
|
|
|b American Chemical Society (ACS),
|c 2015-06-22T16:02:48Z.
|
856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/97501
|
520 |
|
|
|a The design, synthesis, and characterization of enterobactin-antibiotic conjugates, hereafter Ent-Amp/Amx, where the β-lactam antibiotics ampicillin (Amp) and amoxicillin (Amx) are linked to a monofunctionalized enterobactin scaffold via a stable poly(ethylene glycol) linker are reported. Under conditions of iron limitation, these siderophore-modified antibiotics provide enhanced antibacterial activity against Escherichia coli strains, including uropathogenic E. coli CFT073 and UTI89, enterohemorrhagic E. coli O157:H7, and enterotoxigenic E. coli O78:H11, compared to the parent β-lactams. Studies with E. coli K-12 derivatives defective in ferric enterobactin transport reveal that the enhanced antibacterial activity observed for this strain requires the outer membrane ferric enterobactin transporter FepA. A remarkable 1000-fold decrease in minimum inhibitory concentration (MIC) value is observed for uropathogenic E. coli CFT073 relative to Amp/Amx, and time-kill kinetic studies demonstrate that Ent-Amp/Amx kill this strain more rapidly at 10-fold lower concentrations than the parent antibiotics. Moreover, Ent-Amp and Ent-Amx selectively kill E. coli CFT073 co-cultured with other bacterial species such as Staphylococcus aureus, and Ent-Amp exhibits low cytotoxicity against human T84 intestinal cells in both the apo and iron-bound forms. These studies demonstrate that the native enterobactin platform provides a means to effectively deliver antibacterial cargo across the outer membrane permeability barrier of Gram-negative pathogens utilizing enterobactin for iron acquisition.
|
520 |
|
|
|a Pacific Southwest Regional Center of Excellence for Biodefense and Emerging Infectious Disease
|
520 |
|
|
|a Kinship Foundation. Searle Scholars Program
|
520 |
|
|
|a Massachusetts Institute of Technology. Department of Chemistry
|
546 |
|
|
|a en_US
|
655 |
7 |
|
|a Article
|
773 |
|
|
|t Journal of the American Chemical Society
|